Lucira Health, Inc.
LHDXDelisted Apr 12, 2023- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001652724
Lucira Health, Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Mar 13, 2023; 29 institutions reported holding it in 13F filings for Q4 2022, worth $1.04M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Lucira Health, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 28 | 29 | +1 |
| Shares | 22.9M | 9.38M | −13.5M (−59.0%) |
| Value | $24.2M | $1.04M | −$23.2M (−95.7%) |
New holders (5)
Institutions that held Lucira Health, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 68,179 | $8.00K | 0.00% |
| Renaissance Technologies LLC | 29,000 | $3.00K | 0.00% |
| Jane Street Group, LLC | 26,831 | $2.98K | 0.00% |
| Buckingham Strategic Partners | 17,857 | $1.98K | 0.00% |
| Bank of America Corp | 19 | $2 | 0.00% |
Sold out (4)
Institutions that held Lucira Health, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| AlphaCentric Advisors LLC | 320,200 | $339.0K |
| Cypress Point Wealth Management, LLC | 39,000 | $41.0K |
| UBS Group AG | 4,877 | $5.00K |
| Bogart Wealth, LLC | 200 | $0 |